UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047139
Receipt number R000053771
Scientific Title Efficacy test of plant extract on sleep dissatisfied people
Date of disclosure of the study information 2022/03/10
Last modified on 2022/03/11 08:27:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy test of plant extract on sleep

Acronym

Sleep test

Scientific Title

Efficacy test of plant extract on sleep dissatisfied people

Scientific Title:Acronym

Sleep test

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confirmation of the effect of plant extract intake on sleep for sleep dissatisfied people

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

EEG during sleep 1 and 2 weeks after the start of intake of plant extract

Key secondary outcomes

Subjective assessment 1 and 2 weeks after the start of intake of plant extract


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of a food containing plant extract once a day for 2 consecutive weeks

Interventions/Control_2

Intake of a placebo food that does not contain plant extract once a day for 2 consecutive weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy men and women

Key exclusion criteria

1. Volunteers who have been diagnosed and treated for sleep disorders such as insomnia and sleep apnea syndrome
2. Volunteers taking medications that may affect this study (hypnotics, antipsychotics, anxiolytics, antidepressants, etc.)
3. Volunteers who habitually consume 180ml (sake) or more of alcohol once a week
4. Volunteers who drink more than 3 cups of coffee a day, those who cannot limit coffee intake during the test period to less than 1 cup a day
5. Others who are judged by a doctor to be inappropriate for participating in this study

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Masashi
Middle name
Last name Yanagisawa

Organization

University of Tsukuba

Division name

International Institute for Integrative Sleep Medicine

Zip code

305-8575

Address

1-1-1, Tennodai, Tsukuba, Ibaraki, 305-8575, Japan

TEL

+81-029-853-3301

Email

yanagisawa.masa.fu@u.tsukuba.ac.jp


Public contact

Name of contact person

1st name Shoji
Middle name
Last name Fukusumi

Organization

University of Tsukuba

Division name

International Institute for Integrative Sleep Medicine

Zip code

305-8575

Address

1-1-1, Tennodai, Tsukuba, Ibaraki, 305-8575, Japan

TEL

+81-029-853-2786

Homepage URL


Email

fukusumi.shoji.fw@u.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

Tel

+81-03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 11 Month 22 Day

Date of IRB

2021 Year 11 Month 19 Day

Anticipated trial start date

2022 Year 03 Month 19 Day

Last follow-up date

2022 Year 07 Month 21 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 10 Day

Last modified on

2022 Year 03 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053771